G-CSF and G-CSF Biosimilars Market Report

Global and China G-CSF and G-CSF Biosimilars Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 02, 2022
  • PAGES：177
  • REPORT CODE：GMM1429667
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.

    This report elaborates on the current development of the G-CSF and G-CSF Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AstraZeneca

    • GlaxoSmithKline

    • Johnson & Johnson

    • Sanofi

    • Pfizer

    • Roche

    • Novartis

    • AbbVie

    • Gilead Science

    • Amgen

    • Bayer

    • Merck & Co

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Blood Disorders

    • Oncology Diseases

    • Chronic And Autoimmune Diseases

    • Growth Hormone Deficiencies

    Application:

    • Human Growth Hormone

    • Erythropoietin

    • Monoclonal Antibodies

    • Insulin

    • Interferon

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 G-CSF and G-CSF Biosimilars Industry Overview

      • 1.1.1 G-CSF and G-CSF Biosimilars Market Scope and Market Segments

      • 1.1.2 G-CSF and G-CSF Biosimilars Industry Characteristics

      • 1.1.3 Global and China G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China G-CSF and G-CSF Biosimilars Production Value and Growth Rate (2017-2028)

    • 1.2 Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Blood Disorders

      • 1.2.2 Oncology Diseases

      • 1.2.3 Chronic And Autoimmune Diseases

      • 1.2.4 Growth Hormone Deficiencies

    • 1.3 Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Human Growth Hormone

      • 1.3.2 Erythropoietin

      • 1.3.3 Monoclonal Antibodies

      • 1.3.4 Insulin

      • 1.3.5 Interferon

    • 1.4 Market Analysis by Region

      • 1.4.1 North America G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global G-CSF and G-CSF Biosimilars Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 G-CSF and G-CSF Biosimilars Industry Porter's Five Forces Model Analysis

      • 2.2.3 G-CSF and G-CSF Biosimilars Industry PEST Analysis

    • 2.3 G-CSF and G-CSF Biosimilars Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 G-CSF and G-CSF Biosimilars Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on G-CSF and G-CSF Biosimilars Industry

    Chapter 3 Global and China G-CSF and G-CSF Biosimilars Market, by Manufacturer

    • 3.1 Global and China G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China G-CSF and G-CSF Biosimilars Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China G-CSF and G-CSF Biosimilars Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China G-CSF and G-CSF Biosimilars Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China G-CSF and G-CSF Biosimilars Market Top 3 Players

    Chapter 4 Global and China G-CSF and G-CSF Biosimilars Market, by Type (2017-2028)

    • 4.1 G-CSF and G-CSF Biosimilars Market Trend, by Type

    • 4.2 Global G-CSF and G-CSF Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global G-CSF and G-CSF Biosimilars Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global G-CSF and G-CSF Biosimilars Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global G-CSF and G-CSF Biosimilars Price Trend, by Type (2017-2028)

    • 4.3 China G-CSF and G-CSF Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China G-CSF and G-CSF Biosimilars Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China G-CSF and G-CSF Biosimilars Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China G-CSF and G-CSF Biosimilars Price Trend, by Type (2017-2028)

    Chapter 5 Global and China G-CSF and G-CSF Biosimilars Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global G-CSF and G-CSF Biosimilars Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global G-CSF and G-CSF Biosimilars Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China G-CSF and G-CSF Biosimilars Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China G-CSF and G-CSF Biosimilars Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America G-CSF and G-CSF Biosimilars Market Analysis

    • 7.1 North America G-CSF and G-CSF Biosimilars Market, by Type

    • 7.2 North America G-CSF and G-CSF Biosimilars Market, by Application

    • 7.3 North America G-CSF and G-CSF Biosimilars Market Analysis and Forecast, by Country

      • 7.3.1 United States G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe G-CSF and G-CSF Biosimilars Market Analysis

    • 8.1 Europe G-CSF and G-CSF Biosimilars Market, by Type

    • 8.2 Europe G-CSF and G-CSF Biosimilars Market, by Application

    • 8.3 Europe G-CSF and G-CSF Biosimilars Market Analysis and Forecast, by Country

      • 8.3.1 Germany G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC G-CSF and G-CSF Biosimilars Market Analysis

    • 9.1 APAC G-CSF and G-CSF Biosimilars Market, by Type

    • 9.2 APAC G-CSF and G-CSF Biosimilars Market, by Application

    • 9.3 APAC G-CSF and G-CSF Biosimilars Market Analysis and Forecast, by Country

      • 9.3.1 China G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Market Analysis

    • 10.1 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Market, by Type

    • 10.2 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Market, by Application

    • 10.3 Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina G-CSF and G-CSF Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China G-CSF and G-CSF Biosimilars Company Profiles

      • 11.1 AstraZeneca

        • 11.1.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AstraZeneca G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.1.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GlaxoSmithKline

        • 11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.2.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Johnson & Johnson

        • 11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Johnson & Johnson G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.3.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sanofi

        • 11.4.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sanofi G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.4.3 Sanofi G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Pfizer

        • 11.5.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Pfizer G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.5.3 Pfizer G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Roche

        • 11.6.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Roche G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.6.3 Roche G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis

        • 11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.7.3 Novartis G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 AbbVie

        • 11.8.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 AbbVie G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.8.3 AbbVie G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Gilead Science

        • 11.9.1 Gilead Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Gilead Science G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.9.3 Gilead Science G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Amgen

        • 11.10.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Amgen G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.10.3 Amgen G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Bayer

        • 11.11.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Bayer G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.11.3 Bayer G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Merck & Co

        • 11.12.1 Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Merck & Co G-CSF and G-CSF Biosimilars Product Profiles, Application and Specification

        • 11.12.3 Merck & Co G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 G-CSF and G-CSF Biosimilars Industry Investment Prospect and Risk Assessment

    • 12.1 G-CSF and G-CSF Biosimilars Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 G-CSF and G-CSF Biosimilars Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Production Value and Growth Rate (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Production Value and Growth Rate (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Blood Disorders (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Oncology Diseases (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Chronic And Autoimmune Diseases (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Growth Hormone Deficiencies (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Human Growth Hormone (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Erythropoietin (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Insulin (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Market Size and Growth Rate of Interferon (2017-2028)

    • Figure North America G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China G-CSF and G-CSF Biosimilars Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China G-CSF and G-CSF Biosimilars Sales Value, by Manufacturer (2021&2022)

    • Table Global and China G-CSF and G-CSF Biosimilars Market Share, by Manufacturer (2021&2022)

    • Figure Global and China G-CSF and G-CSF Biosimilars Market Share, by Manufacturer in 2021

    • Figure Global and China G-CSF and G-CSF Biosimilars Market Share, by Manufacturer in 2022

    • Table Global G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Value, by Type (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Value Share, by Type (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Price Trend, by Type (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Value, by Type (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Value Share, by Type (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Price Trend, by Type (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Value, by Application (2017-2028)

    • Table Global G-CSF and G-CSF Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure Global G-CSF and G-CSF Biosimilars Sales Value Share, by Application (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Value, by Application (2017-2028)

    • Table China G-CSF and G-CSF Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure North America G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure Europe G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure APAC G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Table North America G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table North America G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure North America G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table North America G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table North America G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure North America G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure United States G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure United States G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Canada G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Canada G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Mexico G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table Europe G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table Europe G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Europe G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Europe G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table Europe G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Europe G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Germany G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Germany G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure UK G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure UK G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure France G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure France G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Italy G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Italy G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Spain G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Spain G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Belgium G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Poland G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Poland G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Russia G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Russia G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Turkey G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table APAC G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table APAC G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure APAC G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table APAC G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table APAC G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure APAC G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure China G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Japan G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Japan G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure India G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure India G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure South Korea G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa G-CSF and G-CSF Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Brazil G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure South Africa G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Argentina G-CSF and G-CSF Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina G-CSF and G-CSF Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Science Product Profiles, Application and Specification

    • Table Gilead Science G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co Product Profiles, Application and Specification

    • Table Merck & Co G-CSF and G-CSF Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US